Skip to content
PeptideAgent

Compounding pharmacies in North Dakota

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The North Dakota State Board of Pharmacy regulates compounding pharmacies in North Dakota. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

North Dakota at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving North Dakota

No verified compounding pharmacies serving North Dakota are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in North Dakota

The North Dakota State Board of Pharmacy licenses pharmacists and permits pharmacies under NDCC chapter 43-15 and adopts rules in NDAC Title 61. Under NDAC chapter 61-08-01, any pharmacy that ships, mails, or delivers prescription drugs into North Dakota must obtain and hold a North Dakota pharmacy permit and follow North Dakota law for the part of its operation that dispenses to North Dakota residents; permits are renewed each year by July 1. NDCC 43-15-35 requires in-state pharmacies to be majority owned by North Dakota-licensed pharmacists, a rule upheld by the U.S. Supreme Court in North Dakota State Board of Pharmacy v. Snyder's Drug Stores (1973). Compounding standards are in NDAC chapter 61-02-01 (pharmacy permits): section 61-02-01-03 requires nonsterile compounding to meet USP chapter 795 and sterile preparations to be compounded, and sterile compounding facilities and equipment to conform, according to USP chapter 797, with hazardous drugs handled under USP chapter 800, and the chapter issues a separate Class C permit to pharmacies that dispense sterile injectable products to the general public. North Dakota has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [3] [4] [5] [7]

Compounded GLP-1 access in North Dakota

Because North Dakota requires a full pharmacy permit for every out-of-state shipper, fewer national telehealth pharmacies serve the state, and patients should confirm the pharmacy's North Dakota permit before ordering. [3] [10]

Research use only sellers in North Dakota

The North Dakota Food, Drug, and Cosmetic Act (NDCC chapter 19-02.1) prohibits selling adulterated or misbranded drugs, and NDCC chapter 43-15 limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners. [5] [6] [11]

North Dakota notes on specific peptides

  • Semaglutide: Available branded by prescription, including by telemedicine from a North Dakota-licensed prescriber who has established a bona fide relationship under NDCC 43-17-44. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [2] [10]

How to check a compounding pharmacy in North Dakota

  1. Search the North Dakota State Board of Pharmacy license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration North Dakota requires before it ships to you. [1] [3] [4] [5] [7]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in North Dakota. [5] [6] [11]

Common questions in North Dakota

Can an out-of-state pharmacy ship compounded peptides to me in North Dakota?

Only if it holds a North Dakota pharmacy permit issued by the State Board of Pharmacy. North Dakota requires every pharmacy that ships prescription drugs into the state to hold a permit and follow North Dakota rules for that dispensing. [1] [3]

Why are most North Dakota pharmacies independently owned?

NDCC 43-15-35 requires in-state pharmacies to be majority owned by North Dakota-licensed pharmacists. The U.S. Supreme Court upheld the law in 1973, and it continues to limit chain pharmacy ownership in the state. [5]

Can a North Dakota pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [7] [8] [9]

All peptide legal questions for North Dakota

Sources

  1. [1]North Dakota State Board of Pharmacy
  2. [2]NDCC 43-17-44, Telemedicine (in chapter 43-17, Physicians and physician assistants)
  3. [3]NDAC chapter 61-08-01, Requirements for out-of-state pharmacies
  4. [4]NDAC chapter 61-02-01, Pharmacy permits (section 61-02-01-03, pharmaceutical compounding standards)
  5. [5]NDCC chapter 43-15, Pharmacy (including 43-15-35, pharmacist ownership)
  6. [6]NDCC chapter 19-02.1, Food, Drug, and Cosmetic Act
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  9. [9]FDA: Pharmacy Compounding Advisory CommitteeFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  11. [11]21 U.S.C. 331, Prohibited acts